# BRCA1/2 and Effect of Mifepristone on the Breast

> **NCT01898312** · PHASE2 · COMPLETED · sponsor: **Karolinska Institutet** · enrollment: 45 (actual)

## Conditions studied

- Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2

## Interventions

- **DRUG:** Mifepristone

## Key facts

- **NCT ID:** NCT01898312
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-01
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2022-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01898312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01898312, "BRCA1/2 and Effect of Mifepristone on the Breast". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01898312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*